» Articles » PMID: 36481862

Correlation of Photoreceptor Damage with Anti-retina Antibodies Level in Aqueous Humor in Macular Edema Patients

Overview
Journal Sci Rep
Specialty Science
Date 2022 Dec 9
PMID 36481862
Authors
Affiliations
Soon will be listed here.
Abstract

This study aimed to investigate the correlation between the severity of photoreceptor damage and the level of anti-retina antibodies (ARAs) in aqueous humor, including recoverin, CA II and enolase-α IgG antibody of macular edema patients. Aqueous humor samples were collected from macular edema patients and from cataract patients. Patients were divided into three groups according to the severity of discontinuity of ellipsoid zone (EZ) shown on optical coherence tomography (OCT) imaging: cataract patients with intact EZ, macular edema patients with mild EZ damage, and macular edema patients with severe EZ damage. The level of ARAs was determined with enzyme-linked immunosorbent assay (ELISA). The correlation between the level of ARAs and the degree of photoreceptor damage was analyzed. The level of ARAs of the intact EZ group was significantly lower than that in the severely damaged group (P < 0.05). The level of recoverin IgG of the intact EZ group was significantly lower than mildly damaged group (P = 0.030). In a subgroup analysis, the level of recoverin IgG of DME patients was correlated with their central retinal thickness (CRT) (r = 0.462, P = 0.035). The level of ARAs in aqueous humor of patients with DME and RVO-ME was correlated with the degree of photoreceptor damage.

Citing Articles

Intravitreal Injections for Macular Edema in Silicone Oil Filled Eyes.

Safadi K, Eshel Y, Levy J, Tiosano L, Jaouni T, Khateb S Clin Ophthalmol. 2024; 18:3405-3416.

PMID: 39600616 PMC: 11590676. DOI: 10.2147/OPTH.S483325.


Circulating Anti-Endothelial Cell Antibodies in Patients with Geographic Atrophy Related to Dry Age-Related Macular Degeneration.

Zuber-Laskawiec K, Wilanska J, Karska-Basta I, Pociej-Marciak W, Romanowska-Dixon B, Sanak M Medicina (Kaunas). 2024; 60(5).

PMID: 38792993 PMC: 11122982. DOI: 10.3390/medicina60050810.

References
1.
Adamus G, Ren G, Weleber R . Autoantibodies against retinal proteins in paraneoplastic and autoimmune retinopathy. BMC Ophthalmol. 2004; 4:5. PMC: 446200. DOI: 10.1186/1471-2415-4-5. View

2.
Ichinohasama R, Nishiguchi K, Fujita K, Aizawa N, Inoue T, Sasaki E . Levels of Anti-Retinal Antibodies in Retinal Detachment and Proliferative Vitreoretinopathy. Curr Eye Res. 2018; 43(6):804-809. DOI: 10.1080/02713683.2018.1451544. View

3.
Ko A, Brinton J, Mahajan V, Zimmerman B, Brinton G, Stone E . Seroreactivity against aqueous-soluble and detergent-soluble retinal proteins in posterior uveitis. Arch Ophthalmol. 2011; 129(4):415-20. DOI: 10.1001/archophthalmol.2011.65. View

4.
Yoshitake S, Murakami T, Suzuma K, Yoshitake T, Uji A, Morooka S . Anti-fumarase antibody promotes the dropout of photoreceptor inner and outer segments in diabetic macular oedema. Diabetologia. 2018; 62(3):504-516. PMC: 6441336. DOI: 10.1007/s00125-018-4773-1. View

5.
Adamus G . Impact of Autoantibodies against Glycolytic Enzymes on Pathogenicity of Autoimmune Retinopathy and Other Autoimmune Disorders. Front Immunol. 2017; 8:505. PMC: 5408022. DOI: 10.3389/fimmu.2017.00505. View